INTEGRATED CORE STRATEGIES (US) LLC - 13 Jun 2025 SCHEDULE 13G Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Astria Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
ATXS
Shares outstanding
56,496,212 shares
Disclosed Ownership
2,937,803 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
18 Jun 2025, 16:03:46 UTC
Date of event
13 Jun 2025
Previous filing
28 Jan 2025
Next filing
20 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.2% ownership in Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS) on 13 Jun 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS).
  • Disclosed ownership: 5.2%.
  • Date of event: 13 Jun 2025.

What Changed

  • Previous schedule filing date: 28 Jan 2025.
  • Current filing was accepted on 18 Jun 2025, 16:03.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.1% 2,868,294 0 2,868,294 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.2% 2,937,803 0 2,937,803 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.2% 2,937,803 0 2,937,803 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.2% 2,937,803 0 2,937,803 /s/ Israel A. Englander Israel A. Englander

Sponsored